Changing the Lives of Type 1 Diabetes Patients
Type 1 diabetes requires constant monitoring. Patients need to check their blood sugar daily and adjust their medication and activities accordingly.
An artificial pancreas developed by researchers here at UVA could change that.
The system has two parts:
- A smartphone that uses an algorithm to automatically deliver the proper amount of insulin and control blood sugar levels
- An implanted insulin pump that receives blood sugar levels from the hand-held device every five minutes
The artificial pancreas essentially functions like a healthy pancreas.
Testing the Artificial Pancreas at UVA
The Food and Drug Administration recently approved the first U.S. artificial pancreas clinical trials for patients outside of a hospital. A similar trial in Europe showed patients could maintain safe blood sugar levels while spending a night outside of the hospital. Earlier tests on patients in hospitals in Europe and the United States were also promising.
The Juvenile Diabetes Foundation's Artificial Pancreas Project is an international consortium including teams from:
- The University of California in Santa Barbara
- Montpellier University Hospital in France
- The Universities of Padova and Pavia in Italy
Learn More About the Clinical Trial
Find out more about this clinical trial: Email us.
UVA Research: The Artificial Pancreas App
The artificial pancreas app uses an algorithm to automatically deliver the proper amount of insulin and helps to control blood sugar levels. The technology has been developed by researchers at University of Virginia. View Transcript.